Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Severe obesity is already a significant problem for many children, especially since obese children often become obese adults.

Researchers uncover how liraglutide targets specific brain regions to suppress appetite and promote significant weight loss ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got ...

By week 56, kids, ages 6 to <12 years, on once-daily 3-mg liraglutide lost 5.8% of BMI compared with a 1.6% gain with ...

The obesity medication liraglutide is safe and effective in children aged 6 to <12 years, new research being presented at the ...

These RCT findings support safety and efficacy in 6 to 12 year olds, but there are many unanswered questions, one expert says ...

The weight-loss drug liraglutide (Saxenda) helped obese children lower their BMI and reach a healthier weight, researchers ...

Liraglutide plus lifestyle intervention is efficacious for children aged 6 to <12 years with obesity, according to a study ...

Novo Nordisk asked US regulators to approve the drug for children ages 6 to 11. In the EU, it's available for adolescents as ...